Akhil Farma Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51397MH1990PLC055739 Incorporated 09 March 1990 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Revenue · FY 2025
₹5.29 Lakh
▲ 1009.62% YoY
Net profit · FY 2025
₹2.51 Lakh
Net margin 47.5%
EBITDA · FY 2025
₹4.37 Lakh
EBITDA margin 82.6%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹41.9 Lakh
Issued & subscribed
Open charges
₹8 Lakh
Secured borrowings
Company age
36 yrs
Est. 1990
Directors on board
3
As per MCA filings

About Akhil Farma Limited

Data last updated:

Akhil Farma Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 March 1990 and has been in existence for over 36 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH1990PLC055739. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹41.9 Lakh. It is led by directors including Chandrayani Venugopal Nayak (Whole-Time Director) and Anil Nadkarni (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 142 Chaswala Estates V Road Jogeshwari West, Mumbai, Maharashtra, India – 400102.

As per the financials filed for FY 2025, the company reported a revenue of ₹5.29 Lakh. For the same year it recorded a net profit of ₹2.51 Lakh (net margin 47.5%) and EBITDA of ₹4.37 Lakh (EBITDA margin 82.6%). Revenue has grown at a compounded annual rate (CAGR) of 61% over three years and 36% over five years.

As per MCA filings, the company has open charges of ₹8 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51397MH1990PLC055739
Registration Number 055739
Incorporation Date 09 March 1990
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Akhil Farma has one previous CIN (Corporate Identification Number): U51397MH1990PTC055739. The current CIN is U51397MH1990PLC055739, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51397MH1990PLC055739Current
U51397MH1990PTC055739Previous

Contact details

Akhil Farma Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    142 Chaswala Estates V Road Jogeshwari West, Mumbai, Maharashtra, India – 400102
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Akhil Farma Limited, buy the company report.

Comprehensive company report
Akhil Farma Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Akhil Farma Limited

FY 2025 filings available

Akhil Farma Limited reported revenue of ₹5.29 Lakh for FY 2025.

Revenue · FY 2025
₹5.29 Lakh
Net profit · FY 2025
₹2.51 Lakh margin 47.5%
EBITDA · FY 2025
₹4.37 Lakh margin 82.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▼ 61%
5 years · compounded
▲ 36%
EBITDA CAGR growth
1 year
▲ 14%
3 years · compounded
▼ 63%
5 years · compounded
▲ 51%

Revenue has grown at a compounded annual rate (CAGR) of 36% over five years. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.37 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.51 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin82.6%
Net Profit Margin47.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Akhil Farma Limited, buy the company report.

Board of directors of Akhil Farma Limited

Akhil Farma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nomita Ramdas ChandavarkarDirector16 Jun 20251 Years 5 MonthsCurrent
Chandrayani Venugopal NayakWhole-Time Director01 Dec 200124 Years 11 MonthsCurrent
Anil NadkarniWhole-Time Director14 Jan 200026 Years 10 MonthsCurrent

Peer comparison

Akhil Farma Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Narshi Pharmaceutical and Surgical Private Limited₹5.35 Lakh (FY 2024)-94.0%New Delhi, Delhi, India
Akhil Farma Limitedthis company₹5.29 Lakh (FY 2025)₹2.51 Lakh47.5%Mumbai, Maharashtra, India
Jaks Suppliers Private Limited₹5.26 Lakh (FY 2021)Mumbai, Maharashtra, India
Access Pharmaceuticals Private Limited₹5.24 Lakh (FY 2025)-98.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Akhil Farma Limited, buy the company report.

Auditor

Akhil Farma Limited is audited by K V S & COMPANY for the financial year 2021.

Auditor firmFinancial yearFirm registration number
K V S & COMPANYFY 2021121478W

Shareholding

The shareholding of Akhil Farma Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Akhil Farma Limited, buy the company report.

Charges & borrowings

Open charges
₹8 Lakh
Satisfied charges
None
Breakdown by lending institutions
Canara Bank₹0.08 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Mar 198790164789Canara Bank₹8 LakhOpen

To see the full charge records of Akhil Farma Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Akhil Farma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Akhil Farma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Akhil Farma Limited, buy the company report.

Recent activity

Akhil Farma Limited has 8 board changes on record since 2000: 3 appointments and 5 cessations. The latest: Nomita Ramdas Chandavarkar ceased to be Additional Director on 29 Sep 2025.

AGM
Akhil Farma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Nomita Ramdas Chandavarkar ceased to be Additional Director.
Appointed
Nomita Ramdas Chandavarkar was appointed as Director.
Filing
Akhil Farma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Meera Ramdas Chandavarkar ceased to be Additional Director.
Ceased
Shailaja Girish Harite ceased to be Director.
Ceased
Anil Nadkarni ceased to be Director.
Ceased
Chandrayani Venugopal Nayak ceased to be Director.
Appointed
Chandrayani Venugopal Nayak was appointed as Whole-Time Director.
Appointed
Anil Nadkarni was appointed as Whole-Time Director.
Charges
A charge with Canara Bank of Rs. 8.00 Lakh registered on 26 Mar 1987 with Charge ID 90164789 was modified on 28 Dec 1990.
Charges
A charge with Canara Bank amounted to Rs. 8.00 Lakh with Charge ID 90164789 was registered on 26 Mar 1987.

1 earlier event is in the company report.

Frequently asked questions

Akhil Farma is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 March 1990 (36+ years old) and is registered under CIN U51397MH1990PLC055739.

Akhil Farma has 3 current directors:

The latest financial statements of Akhil Farma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

No. Akhil Farma has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Akhil Farma is U51397MH1990PLC055739. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Akhil Farma was incorporated on 09 March 1990, making it 36+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Akhil Farma by revenue are Narshi Pharmaceutical and Surgical Private Limited, Jaks Suppliers Private Limited, Access Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Nomita Ramdas Chandavarkar ceased to be Additional Director on 29 Sep 2025. Nomita Ramdas Chandavarkar was appointed as Director on 16 Jun 2025. Meera Ramdas Chandavarkar ceased to be Additional Director on 30 Sep 2015. Akhil Farma has 8 board changes on record in total.

The registered office of Akhil Farma is at 142 Chaswala Estates V Road Jogeshwari West, Mumbai, Maharashtra, India – 400102.

Akhil Farma operates in the pharma industry, in the drug formulation and development segment.

Akhil Farma has open charges of ₹8 Lakh and no satisfied charges on record as per latest MCA filings.